Holen Sie sich die Stockscreener-App
0.5384
0.30%
-0.0016
Handel nachbörslich:
.54
0.0016
+0.30%
Schlusskurs vom Vortag:
$0.54
Offen:
$0.5469
24-Stunden-Volumen:
2.30M
Relative Volume:
0.41
Marktkapitalisierung:
$162.44M
Einnahmen:
$52.29M
Nettoeinkommen (Verlust:
$-134.84M
KGV:
-0.7179
EPS:
-0.75
Netto-Cashflow:
$-117.11M
1W Leistung:
-0.30%
1M Leistung:
-8.06%
6M Leistung:
-43.75%
1J Leistung:
-34.16%
1-Tages-Spanne:
$0.535
$0.5651
1-Wochen-Bereich:
$0.5341
$0.6049
52-Wochen-Spanne:
$0.4111
$3.179
Sangamo Therapeutics Inc Stock (SGMO) Company Profile
Firmenname
Sangamo Therapeutics Inc
Sektor
Branche
Telefon
(510) 970-6000
Adresse
501 CANAL BLVD., RICHMOND, CA
Vergleichen Sie SGMO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SGMO
Sangamo Therapeutics Inc
|
0.5384 | 162.92M | 52.29M | -134.84M | -117.11M | -0.75 |
|
VRTX
Vertex Pharmaceuticals Inc
|
389.08 | 99.27B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
586.96 | 62.28B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.18 | 59.14B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
707.96 | 43.34B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
300.14 | 36.72B | 3.81B | -644.79M | -669.77M | -6.24 |
Sangamo Therapeutics Inc Stock (SGMO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-13 | Hochstufung | Truist | Hold → Buy |
| 2024-12-10 | Bestätigt | H.C. Wainwright | Buy |
| 2023-11-03 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2023-04-28 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2023-02-27 | Hochstufung | Wedbush | Neutral → Outperform |
| 2023-01-06 | Herabstufung | BofA Securities | Buy → Neutral |
| 2022-06-13 | Fortgesetzt | Wedbush | Neutral |
| 2021-05-04 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2021-01-07 | Fortgesetzt | Guggenheim | Neutral |
| 2021-01-06 | Eingeleitet | Stifel | Hold |
| 2020-12-16 | Fortgesetzt | H.C. Wainwright | Buy |
| 2020-09-08 | Eingeleitet | BofA Securities | Buy |
| 2020-07-07 | Eingeleitet | SunTrust | Buy |
| 2019-08-26 | Eingeleitet | H.C. Wainwright | Buy |
| 2018-11-14 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2018-11-09 | Herabstufung | Guggenheim | Buy → Neutral |
| 2018-10-10 | Eingeleitet | Guggenheim | Buy |
| 2018-06-20 | Eingeleitet | BofA/Merrill | Buy |
| 2017-11-15 | Hochstufung | Piper Jaffray | Neutral → Overweight |
| 2017-06-22 | Fortgesetzt | Jefferies | Buy |
| 2016-11-01 | Herabstufung | Wedbush | Outperform → Neutral |
| 2016-10-19 | Herabstufung | Piper Jaffray | Overweight → Neutral |
| 2015-12-04 | Eingeleitet | Wells Fargo | Outperform |
| 2015-10-23 | Fortgesetzt | Jefferies | Buy |
| 2013-05-03 | Eingeleitet | BioLogic Equity Research | Sell |
| 2011-02-23 | Bestätigt | JMP Securities | Mkt Outperform |
| 2010-07-29 | Bestätigt | Wedbush | Outperform |
| 2009-10-19 | Eingeleitet | Brean Murray | Sell |
| 2009-10-07 | Bestätigt | Leerink Swann | Outperform |
| 2009-08-25 | Bestätigt | JMP Securities | Mkt Outperform |
Alle ansehen
Sangamo Therapeutics Inc Aktie (SGMO) Neueste Nachrichten
How Resilient Is Sangamo Therapeutics Inc. Stock During Economic DownturnsShare Buyback & Safe Entry Point Alerts - Newser
Comparing Sangamo Therapeutics Inc. in custom built stock radarsJuly 2025 Volume & Free Community Consensus Stock Picks - Newser
Using Python tools to backtest Sangamo Therapeutics Inc. strategiesJuly 2025 Selloffs & Breakout Confirmation Trade Signals - Newser
What MACD signals say about Sangamo Therapeutics Inc.Weekly Trend Recap & Comprehensive Market Scan Insights - Newser
Bullish Candlestick Pattern Forms in Sangamo Therapeutics Inc.2025 Analyst Calls & Weekly Market Pulse Alerts - beatles.ru
Short interest data insights for Sangamo Therapeutics Inc.Quarterly Market Summary & Verified Chart Pattern Signals - Newser
Identifying reversal signals in Sangamo Therapeutics Inc.Trade Risk Assessment & Expert Curated Trade Setups - Newser
Does Sangamo Therapeutics Inc. fit your quant trading modelQuarterly Market Review & Fast Gaining Stock Reports - Newser
What Fibonacci levels say about Sangamo Therapeutics Inc. reboundWeekly Market Report & Daily Chart Pattern Signals - Newser
What the charts say about Sangamo Therapeutics Inc. todayMarket Activity Report & Technical Confirmation Trade Alerts - Newser
Sangamo Therapeutics Inc. stock trend outlook and recovery pathFed Meeting & Daily Risk Controlled Trade Plans - Newser
Is Sangamo Therapeutics Inc. building a consolidation baseJuly 2025 Short Interest & AI Powered Market Entry Ideas - Newser
What institutional flow reveals about Sangamo Therapeutics Inc.Trend Reversal & Daily Technical Forecast Reports - Newser
Reversal indicators forming on Sangamo Therapeutics Inc. stock2025 Price Targets & Safe Entry Point Identification - Newser
What is Sangamo Therapeutics Inc.’s valuation compared to sectorBreakout Watch & Verified Momentum Watchlists - sundaytimes.kr
Price momentum metrics for Sangamo Therapeutics Inc. explained2025 Winners & Losers & Precise Trade Entry Recommendations - Newser
Will Sangamo Therapeutics Inc. outperform the marketJuly 2025 PreEarnings & Stock Portfolio Risk Control - Newser
Will Sangamo Therapeutics Inc. stock recover after recent drop2025 Price Targets & Weekly High Momentum Picks - Newser
Quant Funds Rotate Into Sangamo Therapeutics Inc. StockJuly 2025 Highlights & Consistent Profit Focused Trading Strategies - 더경남뉴스
Predicting Sangamo Therapeutics Inc. trend using moving averagesJobs Report & AI Forecast Swing Trade Picks - Newser
Sangamo Therapeutics Inc. Added to Custom Quant Screener Today2025 Short Interest & Smart Swing Trading Techniques - classian.co.kr
Layoff Watch: Is Sangamo Therapeutics Inc. stock showing strong momentumBreakout Watch & Expert Verified Movement Alerts - sundaytimes.kr
Short interest data insights for Sangamo Therapeutics IncAnalyst Downgrade & Consistent Return Strategy Ideas - Newser
Can Sangamo Therapeutics Inc. stock outperform in a bear marketRate Cut & Weekly Watchlist of Top Performers - theviewers.co.kr
Sangamo Therapeutics’ stock falls the most in 16 years after Pfizer ends hemophilia pact - MSN
How to manage a losing position in Sangamo Therapeutics Inc.Fed Meeting & Risk Managed Investment Strategies - Newser
What is the PEG ratio of Sangamo Therapeutics Inc.2025 Key Lessons & High Conviction Trade Alerts - theviewers.co.kr
Is There Enough Volume to Lift Sangamo Therapeutics Inc.2025 Earnings Impact & Smart Allocation Stock Tips - beatles.ru
Analyzing drawdowns of Sangamo Therapeutics Inc. with statistical tools2025 Institutional Moves & Daily Stock Momentum Reports - Newser
Risk adjusted return profile for Sangamo Therapeutics Inc. analyzedTrend Reversal & Risk Adjusted Buy/Sell Alerts - Newser
Long term hold vs stop loss in Sangamo Therapeutics Inc.Quarterly Profit Review & Real-Time Stock Entry Alerts - Newser
Is Sangamo Therapeutics Inc. Stock Overbought or Oversold RSI Indicator Analysis - Newser
Sangamo Therapeutics Inc. stock prediction for this weekJuly 2025 Levels & Technical Entry and Exit Tips - Newser
Custom strategy builders for tracking Sangamo Therapeutics Inc.July 2025 Market Mood & Precise Entry and Exit Recommendations - Newser
Wall Street Zen Upgrades Sangamo Therapeutics (NASDAQ:SGMO) to “Hold” - Defense World
HC Wainwright Analysts Raise Earnings Estimates for SGMO - Defense World
How Sangamo Therapeutics Inc. stock performs during market volatilityQuarterly Market Summary & Verified Swing Trading Watchlist - Newser
Sangamo rises after trial data for Fabry disease therapy - MSN
Smart tools for monitoring Sangamo Therapeutics Inc.’s price actionPortfolio Growth Summary & Fast Gaining Stock Strategy Reports - Newser
What Makes Sangamo (SGMO) a New Buy Stock - sharewise.com
Analyzing Sangamo Therapeutics (NASDAQ:SGMO) & Terns Pharmaceuticals (NASDAQ:TERN) - Defense World
Has Sangamo Therapeutics Inc. formed a bullish divergence2025 Price Targets & Reliable Breakout Stock Forecasts - Newser
Sangamo Therapeutics’ SWOT analysis: genomic medicine firm faces cash crunch - Investing.com
What to expect from Sangamo Therapeutics Inc. in the next 30 daysWeekly Profit Report & Weekly Consistent Profit Watchlists - Newser
Sangamo Therapeutics (SGMO.O) Surges 11.3% on Strong KDJ Signal Amid Mixed Biotech Sector Moves - AInvest
Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Q2 2025 Earnings Call Transcript - Insider Monkey
Finanzdaten der Sangamo Therapeutics Inc-Aktie (SGMO)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.98%
8.06%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):